Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSMA”

612 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 612 results

Not applicableUnknownNCT04116086
What this trial is testing

Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage

Who this might be right for
Prostate Cancer
Sheba Medical Center 50
Early research (Phase 1)Ended earlyNCT03619655
What this trial is testing

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Large-scale testing (Phase 3)Looking for participantsNCT06565247
What this trial is testing

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Who this might be right for
Prostate Cancer
Region Västerbotten 60
Not applicableStudy completedNCT05022576
What this trial is testing

Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy

Who this might be right for
Prostate Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 78
Not applicableLooking for participantsNCT05644080
What this trial is testing

68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma

Who this might be right for
High Grade Glioma
St. Olavs Hospital 10
Early research (Phase 1)Temporarily pausedNCT00664196
What this trial is testing

Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning

Who this might be right for
Prostate Cancer
Roger Williams Medical Center 18
Not applicableLooking for participantsNCT07184970
What this trial is testing

PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound

Who this might be right for
Prostate Cancer
NYU Langone Health 60
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Not applicableLooking for participantsNCT06859203
What this trial is testing

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich 94
Testing effectiveness (Phase 2)Study completedNCT02488070
What this trial is testing

68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Carcinoma
Stanford University 10
Not applicableLooking for participantsNCT06209853
What this trial is testing

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Who this might be right for
Prostatic Neoplasms
Assiut University 59
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Not applicableLooking for participantsNCT03327675
What this trial is testing

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 188
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Not applicableLooking for participantsNCT06600802
What this trial is testing

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Metastatic Prostate CancerTreated by 177Lutetium-PSMA-617 (Lu-PSMA)
Centre Jean Perrin 120
Early research (Phase 1)Looking for participantsNCT05656573
What this trial is testing

CART-PSMA Cells for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Nova Therapeutics LLC 20
Early research (Phase 1)Looking for participantsNCT04167969
What this trial is testing

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT06526299
What this trial is testing

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
University of Washington 51
Load More Results